Summers Value Partners Q3 2025 Partner Letter [Seeking Alpha]
Liquidia Corporation (LQDA)
Last liquidia corporation earnings: 3/11 07:00 am
Check Earnings Report
Company Research
Source: Seeking Alpha
The healthcare sector has experienced a year of challenges leading to underperformance versus the broader indexes. These crosscurrents have made the healthcare sector one of the most complex corners of the stock market to navigate, souring sentiment. Underlying fundamentals point to a defensive and growing sector poised to reward disciplined, research-driven investors. Following many years of underperformance, we believe biopharma stocks are poised for outperformance going forward. cemagraphics/E+ via Getty Images Dear Fellow Partners: The Summers Value Fund LP ("the Fund") returned 20.4% net 1 in Q3 2025, beating the Russell 2000 Index ETF ( IWM ), which returned 12.4%, and the Russell 2000 Value Index ETF ( IWN ), which returned 12.5%. Year-to-date, the Fund is up 4.9% net 1 , underperforming the IWM (10.3%), and the IWN (8.9%). Since inception, the Fund has delivered a 12.2% annualized net 1 return compared to 6.8% for IWM and 6.1% for IWN. Trailing Period Returns
Show less
Read more
Impact Snapshot
Event Time:
LQDA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LQDA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LQDA alerts
High impacting Liquidia Corporation news events
Weekly update
A roundup of the hottest topics
LQDA
News
- Raymond James Remains Bullish on Liquidia (LQDA), Cites YUTREPIA's 75% Growth in U.S. Prostacyclin Revenue [Yahoo! Finance]Yahoo! Finance
- Liquidia (NASDAQ:LQDA) had its "buy" rating reaffirmed by analysts at HC Wainwright.MarketBeat
- Liquidia (NASDAQ:LQDA) had its price target raised by analysts at Needham & Company LLC from $36.00 to $52.00. They now have a "buy" rating on the stock.MarketBeat
- Liquidia (NASDAQ:LQDA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $49.00 price target on the stock.MarketBeat
- Liquidia (NASDAQ:LQDA) had its "strong-buy" rating reaffirmed by analysts at Raymond James Financial, Inc..MarketBeat
LQDA
Earnings
- 11/3/25 - Beat
LQDA
Sec Filings
- 12/2/25 - Form 4
- 12/2/25 - Form 4
- 12/2/25 - Form 4
- LQDA's page on the SEC website